AFP and hepatocellular carcinoma: Based on these findings, two alpha-fetoprotein (AFP)-derived peptides, AFP 357 and AFP 403, were identified as attractive compounds to activate cytotoxic T cells in patients with HCC, and preclinical and clinical studies were conducted using these molecules.